Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.43
+0.08005.93%
Post-market: 1.40-0.0300-2.10%19:52 EDT
Volume:17.15M
Turnover:24.39M
Market Cap:912.36M
PE:-10.80
High:1.47
Open:1.37
Low:1.34
Close:1.35
52wk High:4.83
52wk Low:1.09
Shares:638.02M
Float Shares:538.90M
Volume Ratio:1.10
T/O Rate:3.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1324
EPS(LYR):-0.2702
ROE:-31.09%
ROA:-9.63%
PB:3.52
PE(LYR):-5.29

Loading ...

Company Profile

Company Name:
Geron
Exchange:
NASDAQ
Establishment Date:
1990
Employees:
229
Office Location:
919 East Hillsdale Boulevard,Suite 250,Foster City,California,United States
Zip Code:
94404
Fax:
- -
Introduction:
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

Directors

Name
Position
Elizabeth G. O'Farrell
Chairman
Harout Semerjian
President and Chief Executive Officer and Director
Gaurav Aggarwal
Independent Director
John F. McDonald
Independent Director
Robert J. Spiegel
Independent Director
Susan M. Molineaux
Independent Director
V. Bryan Lawlis
Independent Director
Dawn C. Bir
Director

Shareholders

Name
Position
Harout Semerjian
President and Chief Executive Officer and Director
Andrew J. Grethlein
Executive Vice President and Chief Operating Officer
Michelle J. Robertson
Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
Shannon T. Odam
Senior Vice President and Chief People Officer
Edward E. Koval
Executive Vice President and Chief Business Officer
Faye Feller
Executive Vice President and Chief Medical Officer
James Ziegler
Executive Vice President and Chief Commercial Officer
Joseph Emile Eid
Executive Vice President, Research and Development
Melissa A. Kelly Behrs
Executive Vice President, Business Operations and Chief Alliance Officer
Scott A. Samuels
Executive Vice President, Chief Legal Officer and Corporate Secretary